Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RTTR

Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis

Ritter Pharmaceuticals logo

About Ritter Pharmaceuticals Stock (NASDAQ:RTTR)

Advanced Chart

Key Stats

Today's Range
$3.37
$3.89
50-Day Range
$0.45
$4.09
52-Week Range
$0.15
$1.27
Volume
45,396 shs
Average Volume
14.23 million shs
Market Capitalization
$157.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RTTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ritter Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RTTR Stock News Headlines

Dr. John D. Ritter
Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
Kristen Ritter
Dr. Harold K. Ritter
Denver Business Journal welcomes new tech reporter
See More Headlines

RTTR Stock Analysis - Frequently Asked Questions

Ritter Pharmaceuticals Inc (NASDAQ:RTTR) announced its earnings results on Friday, May, 1st. The biotechnology company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.04) by $0.01.

Ritter Pharmaceuticals shares reverse split on Friday, March 23rd 2018.The 1-10 reverse split was announced on Thursday, March 22nd 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 22nd 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Ritter Pharmaceuticals (RTTR) raised $20 million in an IPO on Wednesday, June 24th 2015. The company issued 4,000,000 shares at a price of $5.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO and Barrington Research was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ritter Pharmaceuticals investors own include Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), APA (APA), Charles Schwab (SCHW), Genocea Biosciences (GNCA) and Hudson Technologies (HDSN).

Company Calendar

Last Earnings
5/01/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RTTR
CIK
1460702
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.13 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-162.05%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.67
Quick Ratio
3.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.10 per share
Price / Book
34.20

Miscellaneous

Outstanding Shares
46,153,000
Free Float
N/A
Market Cap
$157.84 million
Optionable
Not Optionable
Beta
-0.43
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:RTTR) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners